Suppliers / Unison Pharmaceuticals

Unison Pharmaceuticals

India 815 employees Updated 9 July 2026

Unison Pharmaceuticals is a contract manufacturer based in India. It appears in 55 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with TMDA (TZ), ARCSA (EC) and CDSCO (India). Its GMP standing is certified by CDSCO (India), EAEU_EEC and EMA, among 5 authorities. Customs aggregates show $25.3M of exports covering 979 molecules to 35 destinations in 2025.

0
active US DMFs
0
valid CEPs
5
registered plants
55
filings across 8 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Moraiya, India Not on file
Ahmedabad, India Not on file
ahmedabad 382 213, India Not on file
Ahmedabad, India Not on file
tal sanandmoraiya 382 213ahmedabad, India Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
TMDA (TZ) 22 1
ARCSA (EC) 13 None
CDSCO (India) 6 3
NAFDAC (NG) 5 1
UZPHARM (UZ) 4 None
INVIMA (CO) 3 None
EAEU_EEC None 2
EMA None 2

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $5.1M 18
2025 Not reported $25.3M 35
2024 Not reported $20.1M 31
2023 Not reported $14.4M 21

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Unison Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts